Matthew L. Sherman - Oct 4, 2021 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
EVP & Chief Medical Officer
Signature
/s/ Jeffrey Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Oct 4, 2021
Transactions value $
-$88,199
Form type
4
Date filed
10/6/2021, 04:00 PM
Previous filing
Jun 29, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$88.2K -2.66K -5.46% $33.17 46K Oct 4, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.
F2 Includes 302 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2021.